Neuron protection and function recovery method after focal cerebral arterial thrombosis
By regulating miR-212-5p/PLXNA2, it inhibits nerve damage and promotes functional recovery, and solves the technical problems of neuronal protection and functional recovery after ischemic stroke, significantly improves motor function and brain tissue damage, and achieves neuroprotection and the effect of function recovery.
Patent Information
- Application Number
- CN202310536200.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-12
- Publication Date
- 2024-11-12
AI Technical Summary
After ischemic stroke, how to effectively protect neurons and promote functional recovery, especially through targeted experiments to find miRNAs that protect and restore stroke patients, has become an urgent technical problem.
By regulating miR-212-5p/PLXNA2 to inhibit nerve damage, qRT-PCR was used to detect proinflammatory and anti-inflammatory cytokines in cells, and combined with exosome analysis and behavioral testing, it verified its nerve after ischemic brain injury Protection and functional recovery effects.
miR-212-5p significantly reduces neurological dysfunction through targeting PLXNA2, reduces cerebral infarction volume and neuronal apoptosis, promotes synaptic plasticity and the formation of dendritic spines, significantly improves motor function and brain neural network connection, and exerts a neuroprotective role. .
Smart Images

Figure CN118924898A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of medical rehabilitation, and in particular to a method for neuron protection and functional recovery after focal ischemic stroke using targeted gene technology. Background Art
[0002] Stroke is a common cerebrovascular emergency that can cause severe brain tissue damage. It is caused by the sudden occlusion or rupture of blood vessels, which prevents blood from flowing to the brain. Two major types of stroke have been identified: hemorrhagic stroke and ischemic stroke. Ischemic stroke is characterized by high morbidity, mortality and recurrence, accounting for about 80% of all strokes. Brain damage after permanent or transient focal cerebral ischemia can trigger a series of pathophysiological events, including free radical release, microglial polarization, blood-brain barrier dysfunction, neuronal apoptosis and neuroinflammation. The ischemic penumbra shows increased neuronal apoptosis during the acute phase of cerebral ischemia, and this process is considered to be an important component of cerebral ischemic injury. Salvage of the ischemic penumbra is at the core of the concept of neuroprotection in ischemic stroke.
[0003] In the central nervous system, microglia, as resident immune cells, have dual functions in brain tissue injury, regeneration and repair after ischemic stroke. Microglia are divided into pro-inflammatory M1 and anti-inflammatory M2 types. M2 microglia are thought to play a neuroprotective function by promoting axonal regeneration, remyelination, neurogenesis and angiogenesis. Exosomes are vesicles within multivesicular bodies with a diameter of 30-150 nm, which are secreted by different types of cells in the brain, including microglia, neurons and astrocytes. Once the multivesicular bodies fuse with the plasma membrane, the exosomes are released into the extracellular space while protecting their contents from degradation. They are involved in the transport of functional biochemical substances, such as messenger RNA (mRNA), microRNAs (miRNAs), cytokines and proteins, and therefore participate in cell-to-cell communication by directly transferring genetic material to target cells.
[0004] A recent study showed that exosomal miRNAs exhibit regulatory effects on target cells and may therefore actually represent a new pathway for intracellular communication. Notably, miRNAs are small noncoding RNA molecules that are processed into ribonucleoprotein complexes that bind to target mRNAs, leading to mRNA degradation or translational inhibition. One miRNA can bind to multiple targets and functionally inhibit multiple miRNAs from participating in biological processes at the same time, thereby achieving a therapeutic effect on the disease. According to increasing evidence, miRNAs have important functions in a wide range of neurological diseases, such as spinal cord injury, traumatic brain injury, and stroke. They are essential mediators of endogenous neuroprotective responses to ischemic preconditioning in the brain. In addition, miRNAs play a key role in the establishment of functional neurons by regulating neuronal morphology. Some miRNAs are highly abundant in the brain, where they serve as effectors required for the development and maintenance of neuronal phenotypes. They are also expressed in dendrites, where they are involved in synaptic plasticity by regulating synaptic and dendritic spine structure. Therefore, how to find some miRNAs that play a protective and restorative role in stroke patients through targeted experiments has become a technical problem that urgently needs to be solved. Summary of the invention
[0005] In order to solve the above technical problems, the neuron protection and functional recovery method of the present invention is to inhibit neural damage by regulating miR-212-5p / PLXNA2 to promote neuroprotection and functional recovery after ischemic brain injury. The verification experimental method uses qRT-PCR to detect the levels of intracellular proinflammatory cytokines and anti-inflammatory cytokines in brain tissue, and quantitatively analyzes the phenotypic changes of microglia in the ischemic penumbra of the cortical ischemic penumbra after transient cerebral ischemia to verify neuroprotection and functional recovery. The verification experimental method is to collect microglial exosomes from the ischemic penumbra of the stroke animal model on the third day after surgery, and identify the isolated exosome samples using NTA, TEM and Western blot analysis of exosome surface markers. The verification experimental method is a behavioral test to explore whether miR-212-5p can improve the motor function of MCAO / R animals, specifically using a step walking test.
[0006] Through the above-mentioned recovery method and experimental method, it can be further determined whether the PLXNA2 gene in miR-212-5p can better inhibit neural damage to promote ischemic brain damage. BRIEF DESCRIPTION OF THE DRAWINGS
[0007] Figure 1 The levels of pro-inflammatory cytokines and anti-inflammatory cytokines were measured 6h, 1, 3, 5, and 7 days after surgery;
[0008] Figure 2miRNA sequencing of microglial exosomes 3 days after MCAO / R surgery;
[0009] Figure 3 Treatment with agomir-212-5p reduced neurological deficits 7 days after MCAO / R;
[0010] Figure 4 Treatment with agomir-212-5p reduced infarct volume and alleviated neuronal apoptosis 7 days after MCAO / R;
[0011] Figure 5 Treatment with agomir-212-5p suppressed the expression of PLXNA2 and RhoA / ROCK2 in the ischemic penumbra on day 3 after MCAO / R;
[0012] Figure 6 Treatment with agomir-212-5p promoted synaptic plasticity and attenuated axonal degeneration at day 7 after MCAO / R;
[0013] Figure 7 Treatment with agomir-212-5p promoted the formation of dendritic spines and the growth of dendritic spines at day 7 after MCAO / R surgery;
[0014] Figure 8 Treatment with agomir-212-5p suppressed PLXNA2 and RhoA / ROCK2 expression in PC12 cells;
[0015] Fig. 9 Treatment with agomir-212-5p reduced neuronal apoptosis and axonal degeneration in PC12 cells after OGD / R; Fig.10 Schematic diagram of the potential molecular mechanism by which agomir-212-5p treatment can exert neuroprotective effects and alleviate neuronal damage after ischemic stroke. DETAILED DESCRIPTION
[0016] Figure 1 Determination of pro-inflammatory cytokine levels and anti-inflammatory cytokine levels at 6h, 1, 3, 5, and 7 days after AE surgery. Pro-inflammatory cytokines released by microglia (IL-1β, IL-6, INOS, CD32, and CD86). Anti-inflammatory cytokines released by FH microglia (anti-inflammatory cytokines TGF-β, IL-10, and CD206). I Immunofluorescence staining was used to detect the expression of CD86 (green) and Iba1 (red) in the cortical ischemic penumbra at different time points. J Immunofluorescence staining was used to detect the expression of CD206 (green) and Iba1 (red) at different time points. Scale bar = 50μm. Data are expressed as mean ± standard error (n = 5 per group). Compared with the sham operation group,* P<0.05, ** P<0.01.
[0017] Figure 2 miRNA sequencing of microglial exosomes 3 days after MCAO / R. A, B Nanoparticle tracking analysis and transmission electron microscopy scanning were used to describe microglial exosomes. Scale bar = 200 nm. C Western blot detection of exosome markers CD9, CD63, and CD81. D Microglia were detected by Western blot using microglial marker CD11b. E Heat map showing the differential expression of miRNAs in microglial exosomes 3 days after MCAO / R. F qRT-PCR was used to detect the expression of miR-30c-5p, miR-126a-5p, miR-128-3p, miR-212-5p, and miR-1949 in the cortical ischemic penumbra 3 days after MCAO / R. G Expression levels of miRNA target genes PLXNA2, PTEN, and FOXO3 in the cortical ischemic penumbra 3 days after MCAO / R. H Target sites of miR-212-5p in the 3' untranslated region (3'UTR) of PLXNA2 mRNA. I Map of pmirGLO luciferase reporter vector. J Dual luciferase assay showing the binding of miR-212-5p to the 3'UTR of PLXNA2. Data are presented as mean ± standard error (n = 5 per group). Compared with the sham group, * P<0.05, ** P<0.01; compared with miR-NC group, # P<0.05.
[0018] Figure 3 Treatment with agomir-212-5p reduced neurological deficits and improved motor function 7 days after MCAO / R. A Flowchart of the experiment. B Schematic diagram of the scoring criteria for the step-walk test. C Test results of the step-walk test. D Neurological deficits were scored using the Zea Longa 5-point scheme. E Waveforms of motor evoked potentials (MEPs) in each group. F Amplitude of MEPs in each group. G Latency of MEPs in each group. n=6 per group. H Schematic representation of CatWalk gait analysis. I Running duration (s). J Average running speed (cm / s). K Right forelimb stride (cm). L Right hindlimb stride (cm). Data are expressed as mean ± standard error (n=8 per group). M Results of brain functional connectivity analysis among the four groups. Compared with the sham operation group, * P<0.05, ** P<0.01; compared with the MCAO / R group, # P<0.05, ## P<value is 0.01.
[0019] Figure 4 Treatment with agomir-212-5p reduced the infarct volume and alleviated neuronal apoptosis 7 days after MCAO / R. A. Brain sections were stained with TTC to observe ischemic lesions 7 days after MCAO / R. The white area shows the infarct core. B. Quantitative analysis of the percentage of infarct area. C. H&E staining. Scale bar = 1000 μm (low magnification) and 50 μm (high magnification). D. Nissl staining. Scale bar = 50 μm. E, F. Immunofluorescence staining of NeuN showed the survival of cortical and striatal neurons around the infarct 7 days after MCAO / R. Data are expressed as mean ± standard error (n = 3 per group). Compared with the sham operation group, * P<0.05, ** P<0.01; compared with the MCAO / R group, # P<0.05, ## P<0.01.
[0020] Figure 5 Treatment with agomir-212-5p inhibited the expression of PLXNA2 and RhoA / ROCK2 in the ischemic penumbra on day 3 after MCAO / R. A The asterisk indicates the ischemic penumbra. B The expression of PLXNA2, RhoA and ROCK2 mRNA in the ipsilateral brain was analyzed by qRT-PCR. C Representative images of Western blot of PLXNA2, RhoA and ROCK2 in each group. β-actin was used as an internal reference. D Quantitative analysis of Western blot results. E Immunofluorescence staining of PLXNA2, RhoA and ROCK2 proteins in neurons of each group. Scale bar = 50 μm. Data are expressed as mean ± standard error (n = 4-6 per group). Compared with the sham operation group, * P<0.05, ** P<0.01; compared with the MCAO / R group, # P < 0.05 and, ## P<0.01.
[0021] Figure 6Treatment with agomir-212-5p promoted synaptic plasticity and attenuated axonal degeneration at day 7 after MCAO / R. The ultrastructure of synapses in the ischemic penumbra was analyzed by transmission electron microscopy. Scale bar = 2 μm. B Schematic diagram of presynaptic (purple) and postsynaptic (green) structures. C Number of synapses in the ischemic penumbra of the cerebral cortex in each group. D Width of synaptic space (nm). n = 3 per group. E Immunofluorescence staining showed that MAP-2 (green) was expressed in the ischemic penumbra of the cortex. The nuclei were stained with DAPI and visible in blue. Scale bar = 50 μm. F Representative images of Nogo-A, NgR, and GAP-43 western blots. G Quantitative analysis of Western blot results. n = 4-6 per group. HJ Immunofluorescence staining showed the expression of Nogo-A, NgR, and βIII tubulin in the ischemic penumbra of the cortex. The nuclei were stained with DAPI and visible in blue. Scale bar = 50 μm. Data are expressed as mean ± standard error. * P<0.05, ** P<0.01; compared with the MCAO / R group, # P<0.05, ## P<0.01.
[0022] Figure 7 Treatment with agomir-212-5p promotes the formation of dendritic spines and the growth of dendritic spines on day 7 after MCAO / R surgery. Representative Golgi staining images of rat brains in each group. Scale bar = 50 μm and 20 μm, respectively. B Count the intersection points of apical dendrites as the distance from the center point increases. C The total number of intersection points of apical dendrites. D Count the total number of intersection points of basal dendrites as the distance from the center point increases. E The total number of intersection points of basal dendrites. F The total number of branches of apical dendrites. G The total number of branches of basal dendrites. H Dendritic spine map on apical dendrites. Scale bar = 10 μm. I The density of dendritic spines along apical dendrites. J Dendritic spine map on basal dendrites. Scale bar = 10 μm. The density of dendritic spines along basal dendrites. Data are expressed as mean ± standard error (n = 3 per group). Compared with the sham group, * P<0.05, ** P<0.01; compared with the MCAO / R group, # P<0.05, ## P<value is 0.01.
[0023] Figure 8Treatment with agomir-212-5p inhibited the expression of PLXNA2 and RhoA / ROCK2 in PC12 cells. A Representative Western blot images show the levels of PLXNA2, RhoA and ROCK2 in each group. β-actin was used as an internal reference. B Quantitative analysis of Western blot results. CE Immunofluorescence staining results of PLXNA2, RhoA and ROCK2 (green) proteins in neurons of each group. The cell nucleus was stained with DAPI, and blue was visible. Scale bar = 50μm. FH qRT-PCR was used to detect the mRNA levels of PLXNA2, RhoA and ROCK2 in each group of patients. Data are expressed as mean ± standard error (n = 4-6 per group). Compared with the sham operation group, * P < 0.05 and ** P<0.01; compared with the MCAO / R group, # P < 0.05 and ## P<value is 0.01.
[0024] Fig. 9 Treatment with agomir-212-5p reduced neuronal apoptosis and axonal degeneration in PC12 cells after OGD / R. ACleaved Caspase-3 immunofluorescence staining (green). The nuclei were stained with DAPI and visible in blue. Scale bar = 50 μm. BC Expression levels of Nogo-A and NgR genes in PC12 cells. Gene expression levels were detected by qRT-PCR, with β-actin as an internal reference. DF Immunofluorescence staining shows the expression levels of Nogo-A, NgR and βIII tubulin in PC12 cells. The nuclei were stained with DAPI and visible in blue. Scale bar = 50 μm. Data are expressed as mean ± standard error (n = 5 per group). Compared with the sham group, * P<0.05, ** P<0.01; compared with the MCAO / R group, # P<0.05, ## P<0.01.
[0025] Fig.10 Schematic diagram of the potential molecular mechanism by which agomir-212-5p treatment can exert neuroprotective effects and alleviate neuronal damage after ischemic stroke.
[0026] The levels of intracellular pro-inflammatory and anti-inflammatory cytokines were detected by qRT-PCR, and the time course of phenotypic changes of microglia in the cortical ischemic penumbra after transient cerebral ischemia was quantitatively analyzed. The mRNA expression of M1 microglia-related pro-inflammatory mediators IL-6, IL-1β, and iNOS increased significantly and gradually after cerebral ischemia, reaching a peak at 24h ( Figure 1AC). The expression of CD32 and CD86 gradually increased after ischemia and remained elevated for at least 7 days ( Figure 1 D and E). For M2 microglia-related markers, including TGF-β, IL-10, and CD206, we found in this study that the expression of TGF-β peaked 24 hours after surgery ( Figure 1 F). IL-10 and CD206 are induced after MCAO / R and reach peak levels 3 to 5 days after injury ( Figure 1 G, H). Immunofluorescence staining of CD86 / Iba1 and CD206 / Iba1 in the ischemic penumbra of the cerebral cortex showed that the expression of CD86 gradually increased over time for at least 7 days ( Figure 1 I). In addition, the expression of CD206 on day 7 was significantly lower than that on days 3 and 5 ( Figure 1 J). Therefore, M2 microglial markers were abundantly expressed on the 3rd day after surgery. On the 3rd day after MCAO / R, the expression of miR-212-5p in microglial exosomes from the ischemic penumbra was reduced; 3 days after MCAO / R, microglial exosomes were collected from the ischemic penumbra cortex to further explore the role of microglial exosomal miRNAs in pathological changes after ischemic stroke. The isolated exosome samples were identified using NTA, TEM, and Western blot analysis of exosome surface markers (CD9, CD63, CD81). Figure 2 As shown in A and B, exosomes present a typical cup-shaped membrane vesicle morphology with a diameter of about 30-120 nm. Exosome-specific markers CD9, CD63, and CD81 are all expressed at high levels in the precipitate ( Figure 2 C). Western blot analysis also showed that CD11b was highly expressed in the precipitate ( Figure 2 D) The expression levels of miRNAs in microglial exosomes of pseudomodel and MCAO / R mice were detected by sequencing. The heat map of miRNA expression is shown in Figure 2 E. The changes in miRNA expression were further verified by qRT-PCR. We screened miR-30c-5p, miR-126a-5p, miR-128-3p, miR-212-5p, and miR-1949, which may be the cause of neurodegeneration. The experimental results showed that miRNAs in the ischemic penumbra were significantly downregulated ( Figure 2F). Based on our miRNA sequencing and qRT-PCR results, we found that the expression of miR-212-5p was significantly decreased in the ischemic penumbra, and we selected it for further study. Searching the prediction database identified several predicted mRNA targets of miR-212-5p, which may be involved in the neuroprotective effect of miR-212-5p. The expression levels of PLXNA2, PTEN, and FOXO3 in the ischemic penumbra were examined ( Figure 2 G). Then, a dual luciferase reporter system was performed to validate PLXNA2 as a direct target of miR-212-5p. Transfection of miR-212-5p significantly reduced the luciferase activity in PC12 cells transfected with PLXNA2 wild-type 3'-UTR, but did not inhibit the luciferase activity in cells containing the mutant construct, indicating that PLXNA2 is a direct target of miR-212-5p ( Figure 2 HJ).
[0027] MiR-212-5p can improve motor function recovery and alleviate brain injury;
[0028] Figure 3 A Experimental flow chart. We performed behavioral tests to investigate whether miR-212-5p could improve the motor function of MCAO / R rats, including the step-walk test ( Figure 3 B). After MCAO / R, the right side step error rate was significantly higher than that of the sham operation group, while that of the MCAO / R+agomir-212-5p group was significantly lower than that of the MCAO / R group on the 7th day after surgery ( Figure 3 C). The neurological deficit score of MCAO / R rats was higher, while the neurological deficit score of MCAO / R+agomir-212-5p group was lower than that of MCAO / R group ( Figure 3 D). After MCAO / R, the animals' MEP latency was prolonged and the peak amplitude was reduced. The animals in the MCAO / R+agomir-212-5p group showed significant improvement 7 days after MCAO / R ( Figure 3 EG). In addition, we performed CatWalk gait analysis to assess motor function ( Figure 3 H). After MCAO / R surgery, the longer the run time, the slower the average run speed. Agomir-212-5p shortened the run time to a certain extent ( Figure 3 I), and also increased the average running speed ( Figure 3 J). The stride length of the affected limb was significantly reduced at all measured time points after MCAO / R. The stride length of the rats treated with miR-212-5p was significantly improved compared with that of the MCAO / R rats ( Figure 3K, L). FC analysis results showed that compared with the sham operation group, the functional connectivity between the ipsilateral motor cortex and the contralateral retrosplenial cortex, the ipsilateral sensory cortex, the bilateral caudate nucleus, and the contralateral ventral hippocampus of the rats in the MCAO / R group was reduced. In addition, compared with the sham model group, the functional connectivity between the ipsilateral motor cortex and the ipsilateral motor cortex, the ipsilateral prefrontal cortex, and the contralateral caudate nucleus of the rats in the MCAO / R+agomir-NC group was reduced after modeling. However, compared with the MCAO / R group, the functional connectivity between the ipsilateral motor cortex and the contralateral sensory cortex, the contralateral motor cortex, and the contralateral piriform cortex of the rats in the MCAO / R+agomir-212-5p group was increased. At the same time, compared with the MCAO / R+agomir-+ group, the functional connectivity between the motor cortex and the ipsilateral motor cortex and the contralateral periaqueductal gray matter in the MCAO / R+agomir-212-5p group was increased ( Figure 3 M and Table 3). In summary, agomir-212-5p treatment promoted MEP recovery, enhanced the connectivity of brain neural networks by activating the functional connections between the affected motor cortex and the sensory cortex and the motor cortex of the whole brain, and significantly improved motor behavior.
[0029] We collected the brains of rats on day 7 after MCAO / R and performed TTC staining to examine the effect of agomir-212-5p treatment on cerebral infarct volume ( Figure 4 A). TTC staining showed that the white area in the MCAO / R group increased significantly, while agomir-212-5p administration significantly reduced the infarct volume in MCAO / R rats ( Figure 4 B). This change may indicate that agomir-212-5p has a neuroprotective effect. Tissue sections were stained with H&E and Nissl to show histological changes in neurons and further confirm the neuroprotective effect of miR-212-5p. H&E staining showed that cells in MCAO / R rats were disordered, interstitial edema, and a large number of cells were necrotic ( Figure 4 C). Nissl staining showed that the number of Nissl bodies in the ischemic penumbra of the MCAO / R group was reduced. Agomir-212-5p treatment can effectively improve brain tissue and neuronal damage ( Figure 4 D). NeuN staining further showed that compared with the MCAO / R group, the cortex ( Figure 4 E, F) and striatum ( Figure 4 G, H), neuronal apoptosis was reduced after cerebral ischemia. Taken together, these results indicate that miR-212-5p can effectively alleviate brain damage induced by cerebral ischemia. MiR-212-5p promotes neuroprotection in MCAO / R rats by targeting PLXNA2;
[0030] The mechanism of the neuroprotective effect of miR-212-5p was further investigated by detecting the expression of the miR-212-5p target gene PLXNA2. On day 3 after MCAO / R, qRT-PCR analysis showed that the levels of PLXNA2, RhoA, and ROCK2 were significantly increased, while agomir-212-5p treatment significantly downregulated their expression in the ischemic penumbra ( Figure 5 B). Western blot results were consistent with qRT-PCR results ( Figure 5 C, D). Finally, we detected the expression of PLXNA2, RhoA, and ROCK2 in neurons by immunofluorescence staining, and labeled neurons in the ischemic penumbra with NeuN antibody. Immunofluorescence staining showed that agomir-212-5p attenuated the expression of PLXNA2, RhoA, and ROCK2 in neurons 3 days after MCAO / R ( Figure 5 E) The results suggest that PLXNA2 and RhoA / ROCK2 may be involved in the neuroprotective effect of miR-212-5p.
[0031] MiR-212-5p promotes synaptic plasticity and alleviates axonal degeneration in MCAO / R rats;
[0032] The synaptic structure of the sham group was intact, including complete presynaptic and postsynaptic structures. After MCAO / R surgery, there were fewer synaptic vesicles, blurred or missing synaptic clefts, and abnormal synaptic structures ( Figure 6 A). Presynaptic and postsynaptic structures are shown in light purple and green, respectively ( Figure 6 B). After agomir-212-5p treatment, the number of synapses and the intersynaptic gap were improved ( Figure 6 C, D). We observed a significant decrease in MAP-2 staining density, however, agomir-212-5p treatment reversed this phenomenon ( Figure 6 E). Next, we studied the effect of agomir-212-5p on attenuating axonal degeneration. Western blot results showed that after intervention in the MCAO / R+212-5p group, the expression levels of Nogo-A and NgR were significantly lower than those in the MCAO / R group ( Figure 6 F, G). The results of Nogo-A and NgR immunofluorescence staining were consistent with the results of Western blot experiments ( Figure 6 H, I). Treatment with agomir-212-5p effectively reduced MCAO / R-induced axonal damage ( Figure 6 J). Taken together, these findings suggest that increasing miR-212-5p expression may be a potential strategy to promote synaptic plasticity and inhibit axonal degeneration after MCAO / R-induced focal cerebral ischemia.
[0033] MiR-212-5p promoted the formation and growth of dendritic spines in rats after MCAO / R surgery;
[0034] We evaluated the role of miR-212-5p by measuring the complexity of dendritic architecture in vivo by performing Golgi staining on brain sections. At day 7 after MCAO / R, the complexity of apical and basal dendrites was significantly reduced, and the number of dendritic intersections was reduced in MCAO / R rats ( Figure 7 AE), reduced dendritic branching ( Figure 7 F, G). We also compared the dendritic spine density on the apical dendrites and the basal dendrites. When counting the number of dendritic spines, a significant decrease in dendritic spine density was found after MCAO / R. However, application of agomir-212-5p was able to attenuate the decrease in dendritic spine density ( Figure 7 HK). Taken together, these data suggest that miR-212-5p may play an important role in promoting dendritic spine formation and promoting dendrite growth.
[0035] In vitro experiments further confirmed that miR-212-5p promoted neuroprotection by targeting PLXNA2;
[0036] In the in vitro study, we used PC12 cells in the OGD / R model to evaluate the neuroprotective effect of miR-212-5p. We first investigated the expression levels of PLXNA2, RhoA, and ROCK2 proteins using Western blot analysis. The expression results of PLXNA2, RhoA, and ROCK2 in cells were similar to those in rat brain tissue ( Figure 8 A, B). In addition, after OGD / R injury, the immunofluorescence staining intensity of PLXNA2, RhoA, and ROCK2 increased, but the immunofluorescence staining intensity was reversed in the agomir-212-5p group ( Figure 8 CE). These results were further confirmed by qRT-PCR ( Figure 8 FH). In summary, PLXNA2 may be involved in the action of miR-212-5p.
[0037] MiR-212-5p can alleviate cell apoptosis and axonal degeneration in vitro;
[0038] like Fig. 9 As shown in A, immunofluorescence staining showed that after OGD / R, the level of C-caspase3 was significantly increased, while agomir-212-5p treatment significantly reduced cell death. The mRNA levels of NogoA and NgR in the OGD / R group were higher than those in the agomir-212-5p treatment group ( Fig. 9B, C). Similarly, cell immunofluorescence experiments further confirmed these results. OGD / R increased the expression of Nogo-A and NgR mRNA and decreased the expression of βIII tubulin, while agomir-212-5p treatment significantly reversed these changes ( Fig. 9 DF). These results suggest that miR-212-5p has a neuroprotective effect against cell death in vitro.
[0039] Materials and methods;
[0040] animal
[0041] We obtained adult male SD rats weighing 260–280 g from the Shanghai Experimental Animal Research Center. Only male rats were used in this study because previous studies have demonstrated the neuroprotective effects of estrogen in animal models of cerebral ischemia. We housed all rats under standard laboratory conditions at 23 ± 2 °C, 40%–50% humidity, and a 12 h–12 h light–dark cycle. The animals had access to food and water. The Animal Ethics Committee of Shanghai University of Traditional Chinese Medicine reviewed and approved all experimental protocols, and all animal procedures followed the guidelines of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
[0042] Establishment of ischemic stroke animal model and intracerebroventricular injection;
[0043] Rats were anesthetized with sodium pentobarbital (30 mg / kg, intraperitoneal injection). The rats were then placed in the supine position, and a midline incision was made in the neck to expose the left external carotid artery (ECA), internal carotid artery (ICA), and common carotid artery (CCA). The ECA was ligated with surgical thread to block blood flow, and the left ICA and CCA were temporarily clamped with microvascular clamps. In the ECA, a small incision was made. Then, the thread plug was gently pushed from the ECA stump to the ICA to block blood flow in the MCA. After the thread plug was fixed for 2 h, the ICA perfusion was restored. The rats in the sham group underwent the same surgery except for the insertion of the thread plug.
[0044] The animals were randomly divided into 4 groups: sham operation group, MCAO / R group, MCAO / R+agomir-NC group, and MCAO / R+agomir-212-5p group. According to previous reports, agomir-NC and agomir-212-5p were injected into the lateral ventricle 30 minutes before MCAO / R. The skull was exposed by making an incision along the midline of the scalp. The injection coordinates were based on the bregma, 1 mm posteriorly, 1.5 mm lateral to the midline of the skull (to the left), and 3.5 mm below the skull. Agomir-212-5p or agomir-NC (10 μM in 7 μl) was slowly injected. At the same time, 7 μl of 0.9% sodium chloride was injected into the lateral ventricle of the sham operation group and the MCAO / R group. The needle was kept in place for 5 minutes after injection.
[0045] Isolation of microglial exosomes in the injured brain;. The ischemic penumbra of the cortex was quickly isolated from the left hemisphere. The tissue was digested with collagenase at 37°C for 15 minutes. Then, it was centrifuged at 2000×g and 4°C for 10 minutes to remove cell fibers and debris, and the supernatant was taken. After centrifugation again at 10000×g at 4°C for 30 minutes, the cell debris was removed. After collecting the supernatant, it was filtered through a 0.22μm filter. The sample was centrifuged at 100000×g and 4°C for 70 minutes, and the supernatant was taken out. The precipitate was resuspended with 0.35μl Dulbecco's PBS to obtain an exosome suspension. 1.5μg CD11b antibody was added to 50μl 3% BSA, and the sample was covered and incubated at room temperature for 60 minutes to isolate microglial exosomes. Subsequently, 10μl Pierce TM Streptavidin Plus UltraLink TM Resin was added to 40 μl 3% BSA, covered with samples and incubated at room temperature for 30 min. Then, centrifuged at 800×g for 10 min. After centrifugation, the supernatant was discarded, and microglial exosomes were recovered and stored at 4°C for subsequent analysis.
[0046] Exosome identification;
[0047] Nanoparticle tracking analysis, transmission electron microscopy, and Western blot analysis were applied to identify exosomes. First, exosomes were analyzed by NTA. To measure the size and concentration of exosome particles, we used NTAZetaView PMX 110 and ZetaView8.04.02. The isolated exosome samples were appropriately diluted with 1× PBS. NTA detection was performed at 11 positions and the measurements were recorded. The ZetaView system was calibrated using 110 nm polystyrene particles. The temperature was maintained at approximately 26.26°C-27.21°C. Transmission electron microscopy was used to analyze the exosome morphology. The exosomes were resuspended in 50 μl of 2% PFA, and 5 μl of the exosome suspension was dropped on a Formvar-carbon sample-loaded copper grid and washed three times with PBS. The copper grid was placed on a 50 μl drop of 1% glutaraldehyde for 5 min and then washed. After washing with distilled water, the copper grid was placed on a 50 μl drop of uranyl oxalate (pH 7) for 5 min and then transferred to a 50 μl drop of methylcellulose for 10 min. Excess liquid was removed with filter paper and the sample was allowed to dry for 10 min. Electron micrographs were obtained with a JEOL 1230 transmission electron microscope.
[0048] Western blot was used to analyze the expression of exosome marker proteins CD9, CD63, and CD81. We used CD11b to identify microglia. Exosome samples were first lysed with RIPA buffer, and total proteins were separated on a 12% SDS-PAGE gel, transferred to a PVDF membrane, blocked, and incubated with primary antibodies overnight. Antibodies included CD9, CD63, and ITGAM / CD11b. The PVDF membrane was then incubated with secondary antibodies (1:5000) at room temperature for 1 hour. Protein signals were detected using a UVP imaging system.
[0049] MiRNA sequencing analysis and target gene prediction;
[0050] MiRNA sequencing was performed by Kangcheng Biotechnology Co., Ltd. in Shanghai, China. Total RNA samples were extracted with TRIzol reagent, and the extracted total RNA samples were quality checked and quantified by agarose electrophoresis and Nanodrop. The library was constructed, and the library quality was evaluated using Agilent2100Bioanalyzer. The library was denatured with 0.1M NaOH to generate single-stranded DNA, and finally 51 cycles of sequencing were performed on an Illumina NextSeq 500 sequencer. TargetScan (http: / / targetscan.org / ) and miRDB (http: / / mirdb.org / miRDB / ) were used to predict miRNA target genes, and the common predicted genes were selected as potential target genes of miRNA.
[0051] Dual luciferase reporter gene assay;
[0052] The wild-type PLXNA2 3'UTR (WT) or PLXNA2 3'UTR mutant (MUT) of the miR-212-5p binding site was inserted into the dual-luciferase pmirGLO vector. Luminescence was detected using a dual-luciferase reporter gene assay using a GloMax instrument (Promega).
[0053] Cell culture and oxygen glucose deprivation / reoxygenation (OGD / R) modeling;
[0054] We obtained PC12 cells from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences, and cultured them in DMEM containing 10% fetal bovine serum and 1% penicillin / streptomycin. The cells were cultured at 37°C in 5% CO2. For cell transfection experiments, cells were transfected with 100nM agomir-212-5p or agomir-NC. Cells were used for subsequent experiments 24h after transfection. We then changed the cell culture medium to sugar-free medium. The cells were incubated in a hypoxic incubator at 37°C for 4 hours (1% O2, 94% N2, and 5% CO2). Subsequently, the sugar-free medium was changed to normal culture medium and maintained under standard conditions (5% CO2 and 37°C) for reoxygenation.
[0055] Behavioral testing;
[0056] The Zea Longa score was used to score neurological deficits: 0 = no signs of neurological deficit; 1 = inability to fully extend the right forepaw; 2 = turning in circles to the right; 3 = falling to the right; 4 = inability to walk spontaneously and loss of consciousness.
[0057] Concluding walking test;
[0058] Eight rats were included in each group. We tested the ability of rats to walk on ladders with irregular intervals (1–3 cm) and recorded videos to assess the impairment of right forelimb function after stroke. Scoring was based on the following criteria: 0 = complete miss; 1 = severe slip; 2 = mild slip; 3 = repositioning; 4 = correction; 5 = partial placement; 6 = correct placement. The miss-step rate was the number of steps with a walking score of 0, 1, or 2. To calculate the miss-step rate, we used the following formula: (number of wrong steps of the right forelimb / total number of steps) × 100%.
[0059] Catwalk gait analysis;
[0060] Each group included 8 rats. During the experiment, the room was dark and quiet. Before the formal experiment, the rats underwent a week of adaptive training. The rats were placed at one end of the glass runway, and food was baited at the other end of the runway. A high-speed camera was used under the runway to record the running of the rats. This experiment was conducted before surgery and on the 1st, 3rd, 5th, and 7th days after surgery. The data were collected and analyzed using CatWalk version 10.6 software.
[0061] Motor evoked potential (MEP);
[0062] The Keypoint 9033A07 electromyography / evoked potential instrument produced in Denmark was used for motor evoked potential detection. The detection time point was 7 days after the rat model was established. During the test, the rats were anesthetized by intraperitoneal injection of sodium pentobarbital (30 mg / kg), and then the rats were fixed in a supine position. The recording electrode was placed on the right biceps brachii, and the stimulating electrode was inserted into the rat's upper jaw (close to the left motor cortex of the brain). A single square wave electric pulse was used for stimulation, with a wave width of 100 μs, and the stimulation intensity was gradually increased until the latency and amplitude no longer changed significantly. The changes in the latency and amplitude of the rat's motor evoked potential were recorded.
[0063] resting-state functional magnetic resonance imaging (fMRI);
[0064] A 11.7T magnetic resonance scanner (Bruker, Karlsruhe, Germany) was used to scan the rat brain. Anesthesia was induced by inhalation of 5% isoflurane in rats, and the rats were fixed on the magnetic resonance scanning table in a prone position. Anesthesia was maintained using 1.5% isoflurane combined with 0.05 mg / kg dexmedetomidine. The resting state fMRI used a single-excitation echo planar imaging (EPI) sequence with interlayer scanning, and its parameters were as follows: flip angle = 90°, scanning layer thickness = 0.3 mm, average number of times = 1, repetition time (TR) = 3000 ms, echo time (TE) = 8.142 ms, field of vision (FOV) = 27×27 mm 2Data preprocessing and data analysis were performed using the SPM8 (stastistical paramettic mapping 8) statistical analysis software package (http: / / www.fil.ion.ucl.ac.uk / spm / ) on the Matlab 2014b (MathWorks, USA) platform. First, the data were converted into Nifti format using the Bru2nii toolbox, and then the SPM8 software was used for slice timing and head motion correction. Then, the MRIcroN software was used to remove non-brain tissues and reset the origin of the image to better align the individual brain image with the template brain. Then, normalization and smoothing were performed. The motor cortex on the ipsilateral side (left side) of the lesion was selected as the region of interest (ROI), and the functional connectivity (FC) between the motor cortex on the affected side and each voxel in the whole brain was calculated, and statistical analysis was performed after Fisher's Z transformation. The two-sample t-test method in SPM8 was used to compare the rats in different groups, and the results were presented on the standard rat brain template. P<0.001 was considered statistically significant.
[0065] Assessment of infarct volume;
[0066] The rat brain was quickly removed and frozen at -20°C for 20 min. Subsequently, the frozen brain was coronally sliced with a thickness of 2 mm, for a total of 5 slices. Brain tissue sections were stained with 2% 2,3,5-trihenyl tetrazoliumchloride (TTC), incubated in the dark at 37°C for 20 min, and then fixed with 4% paraformaldehyde. Image J software was used to calculate the cerebral infarction area.
[0067] Western blot;
[0068] Brain tissue and cells were collected and lysed with RIPA lysis buffer. Protein concentration was determined using a BCA kit. After electrophoresis, tissue samples (80 μg) and cell samples (30 μg) were transferred to PVDF membranes and blocked. After blocking, the PVDF membranes were taken out and placed in TBST for washing for 5 min × 3 times. The PVDF membranes were then placed in antibody incubation boxes and shaken at 4 ° C overnight. The next day, the PVDF membranes were placed in the secondary antibody dilution solution and incubated on a shaker at room temperature for 1 hour. Imaging and image acquisition were performed using the American UVP gel imaging system. The grayscale value of the bands was quantitatively analyzed using Image J software.
[0069] H&E and Nissl staining;
[0070] Nissl staining, hematoxylin-eosin (H&E) staining, and immunofluorescence staining The tissue specimens were fixed in 4% paraformaldehyde for 24 h, dehydrated with alcohol gradient, transparentized with xylene, embedded in paraffin, and the brain sections were sliced from front to back in the coronal plane to prepare 5 μm paraffin sections, ensuring that every fifth section was taken. H&E staining and Nissl staining were performed according to the instructions of the kit.
[0071] Immunofluorescence staining;
[0072] Paraffin sections were dewaxed to water, sections were heat-recovered for antigen, 10% goat serum blocking solution containing 0.3% Triton X-100 was added, incubated at room temperature for 1 hour, and incubated with the designated primary antibody at 4°C overnight. PC12 cells were washed with PBS, fixed with 4% paraformaldehyde, permeabilized with 0.3% TritonX-100 in PBS for 15 minutes, and incubated with 10% goat serum albumin at room temperature for 1 hour. Next, the slides were incubated with the primary antibody at 4°C overnight. The next day, the secondary antibody was incubated, the nuclei were counterstained, and the slides were sealed. Images were collected at 400 times the field of view using an inverted fluorescence microscope.
[0073] Fluorescence quantitative PCR (qRT-PCR);
[0074] TRIzol reagent was used to extract RNA from cells and brain tissues, and reverse transcribed into cDNA using a reverse transcription kit. The SYBR Green kit and LightCycler 480 real-time fluorescence quantification instrument were used to detect gene expression levels. The reaction conditions were: pre-denaturation, 95°C for 5 min for 1 cycle; amplification, denaturation at 95°C for 10 s, annealing at 60°C for 10 s, extension at 72°C for 10 s, and a total of 45 cycles. U6 (for miRNA) and β-actin (for mRNA) were used as internal references. Tables 1 and 2 show the primer sequences designed for this study. The relative expression of genes was measured using 2 -△△CT Law
[73] The calculation formula of △△CT is: △△CT=(CT 目的基因 -CT 内参基因 ) 实验组 -(CT 目的基因 -CT 内参基因 ) 对照组 Statistical methods were used to compare whether there were statistical differences in the results among the groups.
[0075] Transmission electron microscopy;
[0076] Cut the brain tissue into 1 mm 3 , fixed with 2.5% glutaraldehyde for 2 hours, then fixed with 1% osmium acid for 1 hour, dehydrated, and embedded. Then, 50 nm ultrathin sections were prepared and stained with uranyl acetate-lead citrate double staining method. Transmission electron microscopy was used for image acquisition.
[0077] Golgi staining, Sholl analysis, and dendritic spine density measurement;
[0078] Golgi staining was performed using the FD Fast Golgi Staining Kit. The extracted brain was immersed in Golgi staining solution in the dark at room temperature for 2 weeks. It was washed with distilled water three times, and 80% glacial acetic acid was poured to immerse the tissue overnight. After the tissue softened, it was washed with distilled water and placed in 30% sucrose. The tissue was cut into slices with a thickness of 100 μm using an oscillating slicer, and the slices were attached to gelatin slides. The tissue slides were treated with concentrated ammonia for 15 minutes, washed with distilled water for 1 minute, treated with fixative for 15 minutes, washed with distilled water for 3 minutes, dried, and sealed with glycerol gelatin. The results were analyzed using Image J, NeuronJ, ShollAnalysis, and NeuronStudio software.
[0079] Statistical analysis;
[0080] The experimental data were statistically analyzed using SPSS 22.0 software and expressed as mean ± standard error (SEM). One-way ANOVA was used for comparison between groups, and the LSD method was used for pairwise comparisons of variance homogeneity, and Dunnet's T3 test was used for unequal variance. P < 0.05 was considered statistically significant.
Claims
1. Methods for neuronal protection and functional recovery after focal ischemic stroke and verification experimental methods, Features: The neuron protection and functional recovery method is to inhibit nerve damage by regulating miR-212-5p / PLXNA2 to promote neuron protection and functional recovery after ischemic stroke.
2. The method for neuronal protection and functional recovery after focal ischemic stroke and the verification experimental method according to claim 1, Features: In the brain tissue of animal models of stroke, miR-212-5p targeted its downstream PLXNA2 gene to inhibit neural damage. The levels of intracellular proinflammatory cytokines and anti-inflammatory cytokines were detected by qRT-PCR in brain tissue. The phenotypic changes of microglia in the cortical ischemic penumbra after transient cerebral ischemia were quantitatively analyzed to verify neuroprotection and functional recovery.
3. The method for neuronal protection and functional recovery after focal ischemic stroke and the verification experimental method according to claim 2, Features: The validation experimental method is to collect microglial exosomes from the ischemic penumbra of the stroke animal model on the third day after surgery, and identify the isolated exosome samples using NTA, TEM and Western blot analysis of exosome surface markers.
4. The method for neuron protection and functional recovery after focal ischemic stroke and the verification experimental method according to claim 2, Features: The verification experimental method is a behavioral test to explore whether miR-212-5p can improve the motor function of MCAO / R animals, specifically using a step-walk test.
Citation Information
Cited By
Electrophysiology monitoring system and method for predicting cerebral aneurysm postoperative muscle strength index
CN120983054A
M2 type microglial cell exosome as well as preparation method and application thereof
CN121065091A
